𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: The TUCC trial

✍ Scribed by Allan M. Ross; Runlin Gao; Karin S. Coyne; Jilin Chen; Kangbao Yao; Yuejin Yang; Xuewen Qin; Shubin Qiao; Min Yao


Book ID
117842536
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
79 KB
Volume
142
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.